Spencer Van Decar

3PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 20, 2025
A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).

Spencer G Van Decar, Elizabeth L Barbera, Alexandra M Adams

|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.

Elizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy

|Aug 03, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.

Elizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams

Pageof 1

Frequent Collaborators

1 joint publications

Todd Smolinsky

1 joint publications

Timothy E Newhook

1 joint publications

Patrick McCarthy

1 joint publications

Timothy Vreeland